Cholecystectomy and Risk of Cardiovascular Disease, All-cause and Cause-specific Mortality: a Systematic Review and Updated Meta-analysis

Overview

Journal PeerJ

Specialties Biology
Environmental Health
General Medicine

Date 2024 Oct 4

PMID 39364358

Authors

Yang Song

Haishu Wang

Yaowen Xu

Affiliations

Soon will be listed here.

Abstract

Objective: Questions remain about the association among cholecystectomy, cardiovascular disease, all-cause and cause-specific mortality. We performed a systematic review and meta-analysis to clarify these associations.

Methods: PubMed, Web of Science, Embase, and Cochrane Library databases were searched up to February 2024. Summary relative risks (RRs) and 95% confidence intervals (CIs) were calculated using a DerSimonian-Laird random effects model.

Results: We screened 16,595 articles and included 14 studies. No significant association was found between cholecystectomy and cardiovascular disease (CVD), with RR being 1.03 (95% CI [0.77-1.37], = 0.848, = 99.6%), even in results with high heterogenous studies excluded (RR 1.20, 95% CI [0.97-1.49], = 0.095, = 77.7%). Same result was proved in its subtype, coronary heart disease (RR 1.06, 95% CI [0.84-1.33], = 0.633, = 96.6%). Cholecystectomy increased CVD risk compared with healthy controls without gallstones (RR 1.19, 95% CI [1.05-1.35], = 0.007, = 83.3%) and lowered CVD risk compared with gallstone carriers (RR 0.62, 95% CI [0.57-0.67], < 0.001, = 82.1%). As for mortality, increase in the risk for all-cause (RR 1.17, 95% CI [1.03-1.34], = 0.020, = 51.6%) and cardiovascular (RR 1.24, 95% CI [1.06-1.47], = 0.009, = 20.7%) mortality, but not for cancer mortality (RR 1.18, 95% CI [0.95-1.47], = 0.131, = 0.0%), were observed after cholecystectomy.

Conclusion: Cholecystectomy may not be associated with the overall development of CVD, as well as CHD. Cholecystectomized patients showed increased CVD risk compared with healthy controls without gallstones, but decreased CVD risk compared with gallstone patients. Increased risk for all-cause and cardiovascular, but not cancer mortality was observed following cholecystectomy.

References

Fairfield C, Wigmore S, Harrison E . Gallstone Disease and the Risk of Cardiovascular Disease. Sci Rep. 2019; 9(1):5830. PMC: 6456597. DOI: 10.1038/s41598-019-42327-2. View

Luo D, Chen X, Dai Y, Kuang F, Kang M, Li B . Cholecystectomy and risk of liver disease: a systematic review and meta-analysis of 27 million individuals. Int J Surg. 2023; 109(5):1420-1429. PMC: 10389609. DOI: 10.1097/JS9.0000000000000332. View

Cortes V, Quezada N, Uribe S, Arrese M, Nervi F . Effect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese Hispanic patients: a pilot study. Lipids Health Dis. 2017; 16(1):129. PMC: 5493064. DOI: 10.1186/s12944-017-0525-3. View

Bortnichak E, Freeman Jr D, OSTFELD A, CASTELLI W, Kannel W, Feinleib M . The association between cholesterol cholelithiasis and coronary heart disease in Framingham, Massachusetts. Am J Epidemiol. 1985; 121(1):19-30. DOI: 10.1093/oxfordjournals.aje.a113978. View

Jornayvaz F, Samuel V, Shulman G . The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. Annu Rev Nutr. 2010; 30:273-90. PMC: 3730129. DOI: 10.1146/annurev.nutr.012809.104726. View

Chen Y, Weng Z, Liu Q, Shao W, Guo W, Chen C . FMO3 and its metabolite TMAO contribute to the formation of gallstones. Biochim Biophys Acta Mol Basis Dis. 2019; 1865(10):2576-2585. DOI: 10.1016/j.bbadis.2019.06.016. View

Shabanzadeh D . The Symptomatic Outcomes of Cholecystectomy for Gallstones. J Clin Med. 2023; 12(5). PMC: 10004100. DOI: 10.3390/jcm12051897. View

Latenstein C, Alferink L, Murad S, Drenth J, van Laarhoven C, de Reuver P . The Association Between Cholecystectomy, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease: A Population-Based Study. Clin Transl Gastroenterol. 2020; 11(4):e00170. PMC: 7263655. DOI: 10.14309/ctg.0000000000000170. View

Volzke H, Baumeister S, Alte D, Hoffmann W, Schwahn C, Simon P . Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion. 2005; 71(2):97-105. DOI: 10.1159/000084525. View

10.

Wang D, Cohen D, Carey M . Biliary lipids and cholesterol gallstone disease. J Lipid Res. 2008; 50 Suppl:S406-11. PMC: 2674701. DOI: 10.1194/jlr.R800075-JLR200. View

11.

Wei C, Chuang S, Lin C, Kung W, Tai H, Tsai K . Reduced risk of stroke following cholecystectomy: A nationwide population-based study. J Gastroenterol Hepatol. 2019; 34(11):1992-1998. DOI: 10.1111/jgh.14678. View

12.

Konyn P, Alshuwaykh O, Dennis B, Cholankeril G, Ahmed A, Kim D . Gallstone Disease and Its Association With Nonalcoholic Fatty Liver Disease, All-Cause and Cause-Specific Mortality. Clin Gastroenterol Hepatol. 2022; 21(4):940-948.e2. DOI: 10.1016/j.cgh.2022.04.043. View

13.

Moon J, Jeong S, Jang H, Koo B, Kim W . Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study. EClinicalMedicine. 2023; 65:102292. PMC: 10632413. DOI: 10.1016/j.eclinm.2023.102292. View

14.

Rosenmuller M, Haapamaki M, Nordin P, Stenlund H, Nilsson E . Cholecystectomy in Sweden 2000-2003: a nationwide study on procedures, patient characteristics, and mortality. BMC Gastroenterol. 2007; 7:35. PMC: 2040147. DOI: 10.1186/1471-230X-7-35. View

15.

Guyatt G, Oxman A, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650):924-6. PMC: 2335261. DOI: 10.1136/bmj.39489.470347.AD. View

16.

Shabanzadeh D, Skaaby T, Sorensen L, Jorgensen T . Screen-detected gallstone disease and cardiovascular disease. Eur J Epidemiol. 2017; 32(6):501-510. DOI: 10.1007/s10654-017-0263-x. View

17.

Zheng Y, Xu M, Li Y, Hruby A, Rimm E, Hu F . Gallstones and Risk of Coronary Heart Disease: Prospective Analysis of 270 000 Men and Women From 3 US Cohorts and Meta-Analysis. Arterioscler Thromb Vasc Biol. 2016; 36(9):1997-2003. PMC: 5001914. DOI: 10.1161/ATVBAHA.116.307507. View

18.

Park S, Kim H, Kang T, Swan H, Ahn H . Cholecystectomy reduces the risk of myocardial and cerebral infarction in patients with gallstone-related infection. Sci Rep. 2022; 12(1):16749. PMC: 9537563. DOI: 10.1038/s41598-022-20700-y. View

19.

Strom B, Schinnar R, Crown V, Soloway R, STOLLEY P, Rosenberg L . Does gallbladder removal protect against subsequent myocardial infarction?. Am J Epidemiol. 1986; 124(3):420-7. DOI: 10.1093/oxfordjournals.aje.a114412. View

20.

Fan L, Chen B, Dai Z . The relation between gallstone disease and cardiovascular disease. Sci Rep. 2017; 7(1):15104. PMC: 5678091. DOI: 10.1038/s41598-017-15430-5. View